Skip to main content
. 2020 Feb 3;9(1):1722385. doi: 10.1080/20013078.2020.1722385

Figure 5.

Figure 5.

Reduction of TJ proteins in ExoHeLa treated HUVECs was not through ubiquitination or autophagy. (a) HUVECs were preconditioned with PBS or MG132 followed by treatment with ExoHeLa as indicated. Protein levels of ZO-1 and CLDN5 were analysed by western blot and quantified. (b) After treated with either PBS or ExoHeLa, HUVECs were visualized under transmission electron microscopy. Autophagosomes were indicated using black arrows. (c) HUVECs were treated with ExoHeLa for specified times, and the protein level of mTOR, P62 and LC3B I/II was analysed by western blot. (d) HUVECs were preconditioned with PBS or CQ followed by treatment with ExoHeLa. ZO-1 and P62 proteins were evaluated by western blot. Quantification of the proteins was shown in the bar graph. (e) Similarly, after HUVECs were treated with 3MA along with ExoHeLa, ZO-1 and CLDN5 proteins were evaluated by western blot. Quantification of the proteins was shown in the bar graph. *P< 0.05, **P< 0.01, ***P< 0.001, ****P< 0.0001.